Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bankruptcy
MedTech
Navidea Biopharmaceuticals files for Chapter 11
Diagnostic and immunotherapy biopharma Navidea’s long and often tortured journey is coming to an end as it files for bankruptcy.
Ben Adams
Oct 10, 2025 8:10am
Exactech to pay $8M to settle defective knee implant lawsuits
Sep 19, 2025 11:20am
CEO props up Aptose's finances to keep biotech from going bust
Jun 17, 2025 10:04am
Wojcicki prevails in 23andMe auction, with final $305M bid
Jun 16, 2025 10:40am
Regeneron’s $256M bid wins 23andMe bankruptcy auction
May 19, 2025 10:37am
Anne Wojcicki steps down to bid on 23andMe’s bankruptcy auction
Mar 24, 2025 10:43am
